Stock NANOFORM FINLAND OYJ
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Nanoform Finland Oyj Nasdaq Helsinki

Equities

FI4000330972

Biotechnology & Medical Research

Business Summary

Nanoform Finland Oyj is a Finland-based company that operates in the global pharmaceutical industry. The Company is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyj’s business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Group’s strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.

Sales per Business

EUR in Million2022Weight2023Weight Delta
Nanotechnology and Drug Particle Engineering
100.0 %
3 100.0 % 3 100.0 % -26.41%

Sales per region

EUR in Million2022Weight2023Weight Delta
Europe
57.0 %
2 56.2 % 1 57.0 % -25.37%
United States
43.0 %
2 43.8 % 1 43.0 % -27.73%

Managers

Managers TitleAgeSince
Edward Hæggström CEO
 Chief Executive Officer 55 31/12/14
Albert Häggström DFI
 Director of Finance/CFO 53 31/12/14
Henri von Haartman IRC
 Investor Relations Contact - 30/04/19
Antonio da Silva PRN
 Corporate Officer/Principal 50 31/12/18
Peter Hänninen LAW
 General Counsel 36 31/08/20
David Rowe PRN
 Corporate Officer/Principal 57 31/12/18
Christian Jones PRN
 Corporate Officer/Principal 44 31/12/17

Members of the board

Members of the board TitleAgeSince
Miguel Laustsen de Oliveira Barreiros Calado CHM
 Chairman 68 01/04/19
Mads Laustsen BRD
 Director/Board Member 67 31/12/18
Albert Häggström DFI
 Director of Finance/CFO 53 31/12/14
Jeanne A. Thoma BRD
 Director/Board Member 64 30/09/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 85,445,164 59,636,291 ( 69.79 %) 0 69.79 %

Shareholders

NameEquities%Valuation
Edward Hæggström
6.331 %
5,409,405 6.331 % 12 M €
Helsingin Yliopiston Rahastot
5.147 %
4,397,719 5.147 % 10 M €
MANDATUM OYJ
5.040 %
4,306,834 5.040 % 10 M €
Fjärde AP-fonden
4.348 %
3,715,050 4.348 % 9 M €
Keskinäinen Työeläkevakuutusyhtiö Varma
3.589 %
3,066,996 3.589 % 7 M €
Keel Capital AB
3.557 %
3,039,112 3.557 % 7 M €
ATP Arbejdsmarkedets Tillægspension
3.161 %
2,700,708 3.161 % 6 M €
Arbejdsmarkedets Tillægspension
3.161 %
2,700,708 3.161 % 6 M €
Kai Falck
3.160 %
2,700,000 3.160 % 6 M €
Jouko Yliruusi
3.143 %
2,685,182 3.143 % 6 M €

Company contact information

Nanoform Finland Oyj

Cultivator II Viikinkaari 4

00790, Helsinki

+358 2937 00150

http://www.nanoform.fi
address Nanoform Finland Oyj

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per region

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+33.63% 50.85B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.09% 42.82B
LONZA GROUP AG Stock Lonza Group AG
+49.62% 42.03B
CELLTRION, INC. Stock Celltrion, Inc.
-4.96% 29.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.18% 26.11B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.95% 19.13B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.61% 13.05B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.31% 12.16B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.73% 12.08B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. NANOFH Stock
  4. Stock
  5. Company Nanoform Finland Oyj